Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes (Q36524312)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 January 2016
edit
Language Label Description Also known as
English
Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes
scientific article published on 7 January 2016

    Statements

    Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetes (English)
    Tsuyoshi Mashitani
    Ryuichi Noguchi
    Yasushi Okura
    Tadashi Namisaki
    Akira Mitoro
    Hitoshi Ishii
    Toshiya Nakatani
    Eiryo Kikuchi
    Hiroto Moriyasu
    Masami Matsumoto
    Tatsuichi An
    Hiroshi Morita
    Sigeyuki Aizawa
    Yasunori Tokuoka
    Masatoshi Ishikawa
    Yoshinobu Matsumura
    Hiromasa Ohira
    Atsuko Kogure
    Kazuhiro Noguchi
    Hitoshi Yoshiji
    7 January 2016
    183-187

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit